Related references
Note: Only part of the references are listed.Economic burden of Huntington disease in Europe and the USA: Results from the Huntington's Disease Burden of Illness study
Idaira Rodriguez-Santana et al.
EUROPEAN JOURNAL OF NEUROLOGY (2023)
Health care resource utilization and costs among individuals with vs without Huntington disease in a US population
Tu My To et al.
Journal of Managed Care & Specialty Pharmacy (2023)
Healthcare resource utilization and costs in individuals with Huntington's disease by disease stage in a US population
Alex Exuzides et al.
JOURNAL OF MEDICAL ECONOMICS (2022)
Epidemiology of Huntington's Disease in the United States Medicare and Medicaid Populations
Alex Exuzides et al.
NEUROEPIDEMIOLOGY (2022)
Neuropsychiatric comorbidities in Huntington's and Parkinson's Disease: A United States claims database analysis
Lianna Ishihara et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Healthcare utilization and cost burden of Huntington's disease among Medicare beneficiaries in the United States
Alex Exuzides et al.
JOURNAL OF MEDICAL ECONOMICS (2021)
Current and projected future economic burden of Parkinson's disease in the U.S.
Wenya Yang et al.
NPJ PARKINSONS DISEASE (2020)
Medicare Cost at End of Life
Ian Duncan et al.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2019)
Utilization of Hospice Services in a Population of Patients With Huntington's Disease
Margaret O. Johnson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2018)
Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders
Karen E. Anderson et al.
JOURNAL OF HUNTINGTONS DISEASE (2018)
Hospitalizations of Children with Huntington's Disease in the United States
Adys Mendizabal et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2017)
Neuropsychiatric Burden in Huntington's Disease
Ricardo Augusto Paoli et al.
BRAIN SCIENCES (2017)
The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease
Jae Whan Keum et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
The societal cost of Huntington's disease: are we underestimating the burden?
C. Jones et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Interventional Differences Among Huntington's Disease Patients by Disease Progression in Commercial and Medicaid Populations
Karen E. Anderson et al.
JOURNAL OF HUNTINGTONS DISEASE (2014)
The direct medical costs of Huntington’s disease by stage. A retrospective commercial and Medicaid claims data analysis
Victoria Divino et al.
JOURNAL OF MEDICAL ECONOMICS (2013)
The incidence and prevalence of Huntington's disease: A systematic review and meta-analysis
Tamara Pringsheim et al.
MOVEMENT DISORDERS (2012)
Depression in the early stages of Huntington disease
Eric A. Epping et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2011)
All-Cause Health Care Utilization and Costs Associated with Newly Diagnosed Multiple Sclerosis in the United States
Carl V. Asche et al.
JOURNAL OF MANAGED CARE PHARMACY (2010)
EUROPEAN-HUNTINGTON'S DISEASE BURDEN STUDY (EURO-HDB) - PRELIMINARY RESULTS FOR ITALY AND FRANCE
J. Dorey et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration
Jan P. Vandenbroucke et al.
PLOS MEDICINE (2007)
No going home for hospitalized Huntington's disease patients
RM Dubinsky
MOVEMENT DISORDERS (2005)